Tech Company Financing Transactions
Yemaachi Biotechnology Funding Round
Yemaachi Biotechnology secured a $3 million Seed investment round on 3/21/2022. Investors included V8 Capital, private investors and Lifeline Ventures.
Transaction Overview
Company Name
Announced On
3/21/2022
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Seed
Investors
V8 Capital (Lead Investor)
private investors (Ethan Perlstein)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
222 Swaniker Street, Abelempke,
Accra, Undisclosed
Ghana
Accra, Undisclosed
Ghana
Phone
Website
Email Address
Overview
Operator of cancer detection and cure platform intended to redefine how cancer is diagnosed and treated in Africa. The company's platform uses cutting-edge immunogenomics, bioinformatics and artificial intelligence to accelerate the development of cancer detection and treatment strategies, enabling patients to get cured effectively.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yaw Bediako
Co-Founder
Joyce Ngoi
Browse more venture capital transactions:
Prev: 3/20/2022: KnownOrigin venture capital transaction
Next: 3/21/2022: Lune venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record tech company VC transactions. All VC database entries on this site come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs